Nasdaq · CIK 0002029769
OACC Oaktree Acquisition Corp. III Life Sciences
Insider trading from SEC Form 4. Last filing Oct 31, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
1
with a Form 4 at this company
Signals
Open-market buys and sells at Oaktree Acquisition Corp. III Life Sciences, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 4 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 30, 2024 | Oaktree Acquisition Holdings III LS, LLC owner | CConversion Class A ordinary shares | +33,981 | $10.00 | $340k | 583,981 | Oct 31, 2024 |
| Oct 30, 2024 | Oaktree Acquisition Holdings III LS, LLC owner | JOther Class B ordinary sharesderivative | -231,492 | $0.00 | $0 | 4,799,758 | Oct 31, 2024 |
| Oct 30, 2024 | Oaktree Acquisition Holdings III LS, LLC owner | CConversion Private placement warrantsderivative | +6,796 | - | - | 116,796 | Oct 31, 2024 |
| Oct 30, 2024 | Oaktree Acquisition Holdings III LS, LLC owner | CConversion Private placement units (obligation to buy)derivative | -33,981 | - | - | 0 | Oct 31, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.